跳至主要内容
临床试验/IRCT20220205053947N1
IRCT20220205053947N1尚未招募2 期

Assessing the safety and efficacy of Tranexamic Acid and cetirizine versus Cetirizine alone in relieving the symptoms of Chronic Urticaria; a triple-blind Randomized Clinical Trial

Shiraz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
12 years 至 no limit(—)
性别
All

入选标准

  • Patients older than 12 years old
  • Patients with spontaneous chronic urticaria, according to the criteria of the European Academy of Allergology and Clinical Immunology (EAACI) in agreement with the European Dermatology Forum (EDF), and the World Allergy Organization (WAO), corresponding to an association of the following symptoms: urticarial eruptions and/or recurrent angioedema for at least 6 weeks

排除标准

  • Urticaria associated with a specific systematic disease including cutaneous and systemic mastocytosis
  • Urticarial vasculitis
  • Autoinflammatory diseases associated with cryopyrin
  • Bradykinin angioedema
  • Isolated angioedema whose origin is not clearly attributable to spontaneous chronic urticaria
  • Presence of a contraindication to Tranexamic Acid and to Cetirizine such as any history of thromboembolic events as pulmonary thromboembolism and deep vein thrombosis
  • Coagulopathy.
  • Unwillingness of the patients or their legal guardians to participate in the study

研究者

相似试验